Eyecare technology company Sight Sciences (NASDAQ:SGHT) stock price has dropped 28% as the company gives out Q3 guidance and expects Q3 total revenue to be in the range of $19M to $20M.
The company also updates its revenue guidance expectations for FY 2023 to $80M to $82M, which represents growth